Literature DB >> 27563647

Overview of advances in cancer immunotherapy.

Vassiliki Kotoula, George Fountzilas.   

Abstract

Entities:  

Year:  2016        PMID： 27563647      PMCID： PMC4971370          DOI： 10.21037/atm.2016.07.09

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  19 in total

Review 1.  The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications.

Authors:  Panagiota Economopoulou; Christos Perisanidis; Evaggelos I Giotakis; Amanda Psyrri
Journal:  Ann Transl Med       Date:  2016-05

Review 2.  Towards tumor immunodiagnostics.

Authors:  Helen Kourea; Vassiliki Kotoula
Journal:  Ann Transl Med       Date:  2016-07

Review 3.  Inflammation and cancer: back to Virchow?

Authors:  F Balkwill; A Mantovani
Journal:  Lancet       Date:  2001-02-17       Impact factor: 79.321

4.  Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations.

Authors:  Axel Hoos
Journal:  Nat Rev Drug Discov       Date:  2016-03-11       Impact factor: 84.694

Review 5.  Neoantigen-based cancer immunotherapy.

Authors:  Sara Bobisse; Periklis G Foukas; George Coukos; Alexandre Harari
Journal:  Ann Transl Med       Date:  2016-07

Review 6.  Harnessing the immune system to improve cancer therapy.

Authors:  Nikos E Papaioannou; Ourania V Beniata; Panagiotis Vitsos; Ourania Tsitsilonis; Pinelopi Samara
Journal:  Ann Transl Med       Date:  2016-07

Review 7.  The Role of Surgical Pathology in Guiding Cancer Immunotherapy.

Authors:  Scott B Lovitch; Scott J Rodig
Journal:  Annu Rev Pathol       Date:  2016-05-23       Impact factor: 23.472

Review 8.  Bacteria in cancer therapy: a novel experimental strategy.

Authors:  S Patyar; R Joshi; D S Prasad Byrav; A Prakash; B Medhi; B K Das
Journal:  J Biomed Sci       Date:  2010-03-23       Impact factor: 8.410

9.  Statistical Considerations in Clinical Trial Design of Immunotherapeutic Cancer Agents.

Authors:  George Dranitsaris; Roger B Cohen; Gary Acton; Llew Keltner; Melissa Price; Eitan Amir; Eckhard R Podack; Taylor H Schreiber
Journal:  J Immunother       Date:  2015-09       Impact factor: 4.456

Review 10.  Immune-related adverse events with immune checkpoint blockade: a comprehensive review.

Authors:  J M Michot; C Bigenwald; S Champiat; M Collins; F Carbonnel; S Postel-Vinay; A Berdelou; A Varga; R Bahleda; A Hollebecque; C Massard; A Fuerea; V Ribrag; A Gazzah; J P Armand; N Amellal; E Angevin; N Noel; C Boutros; C Mateus; C Robert; J C Soria; A Marabelle; O Lambotte
Journal:  Eur J Cancer       Date:  2016-01-05       Impact factor: 9.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.